Nifty 17469.75 (1.71%)
Sensex 58649.68 (1.76%)
Nifty Bank 37284.7 (1.82%)
Nifty IT 35959.05 (1.95%)
Nifty Financial Services 18284.95 (1.70%)
Adani Ports 761.40 (2.24%)
Asian Paints 3108.50 (2.58%)
Axis Bank 697.10 (1.47%)
B P C L 391.15 (0.86%)
Bajaj Auto 3332.05 (1.39%)
Bajaj Finance 7361.50 (3.64%)
Bajaj Finserv 17621.65 (3.00%)
Bharti Airtel 715.15 (2.33%)
Britannia Inds. 3575.75 (2.92%)
Cipla 897.95 (0.98%)
Coal India 150.90 (0.17%)
Divis Lab. 4604.95 (-0.43%)
Dr Reddys Labs 4570.70 (1.11%)
Eicher Motors 2505.55 (1.37%)
Grasim Inds 1716.25 (1.82%)
H D F C 2853.00 (1.26%)
HCL Technologies 1171.60 (1.91%)
HDFC Bank 1553.80 (1.84%)
HDFC Life Insur. 686.40 (-1.15%)
Hero Motocorp 2490.65 (1.17%)
Hind. Unilever 2340.60 (0.82%)
Hindalco Inds. 457.45 (3.38%)
I O C L 120.40 (-0.17%)
ICICI Bank 753.40 (2.55%)
IndusInd Bank 945.30 (2.01%)
Infosys 1753.35 (2.44%)
ITC 224.95 (1.95%)
JSW Steel 672.95 (1.86%)
Kotak Mah. Bank 1920.45 (-0.86%)
Larsen & Toubro 1825.05 (1.50%)
M & M 840.75 (1.79%)
Maruti Suzuki 7434.90 (3.46%)
Nestle India 19479.10 (0.70%)
NTPC 127.25 (1.52%)
O N G C 148.40 (1.71%)
Power Grid Corpn 204.80 (-0.49%)
Reliance Industr 2418.10 (1.52%)
SBI Life Insuran 1169.50 (0.89%)
Shree Cement 26106.90 (1.40%)
St Bk of India 491.55 (3.12%)
Sun Pharma.Inds. 757.55 (1.86%)
Tata Consumer 772.15 (1.51%)
Tata Motors 493.90 (2.51%)
Tata Steel 1173.00 (2.11%)
TCS 3626.90 (1.18%)
Tech Mahindra 1604.80 (1.79%)
Titan Company 2405.55 (1.05%)
UltraTech Cem. 7423.95 (1.71%)
UPL 728.10 (0.16%)
Wipro 641.70 (1.47%)
PANACEABIO

Panacea Biotec Ltd.

₹202.6
Not a customer?

Open free demat account
& trade instantly

Investment Ratings

  • Master Rating:
  • Panacea Biotec (Nse) has an operating revenue of Rs. 674.65 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of -23% needs improvement, NULL The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 3 which is a POOR score indicating inconsistency in earnings, a RS Rating of 3 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 146 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Analyst Recommendation : HOLD

Panacea Biotec Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Ratings

Eps And Sales Estimates

Panacea Biotec Ltd Synopsis

NSE-Medical-Generic Drugs

Panacea Biotec L is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 343.56 Cr. and Equity Capital is Rs. 6.13 Cr. for the Year ended 31/03/2021. Panacea Biotec Ltd. is a Public Limited Listed company incorporated on 02/02/1984 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L33117PB1984PLC022350 and registration number is 022350.
  • Market Cap

    INR 1,240.95 Cr

  • Sales

    INR 304.40 Cr

  • Shares in Float

    1.59 Cr

  • No of Funds

    3 K

  • Yield

    %

  • Book Value

    2.54

  • U/D Vol Ratio

    0.5

  • LTDebt/Equity

    12%

  • Alpha

    -0.07

  • Beta

    0.77

Panacea Biotec Ltd Ownership
Panacea Biotec Ltd Management

Panacea Biotec Ltd Financials

INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Total ShareHolders Funds Annual Cr 489.96873.837419.377387.918454.668
Fixed Assets Annual Cr 477.218503.016499.542928.089969.698
Total Non Current Assets Annual Cr 499.02524.169525.9281319.8371372.377
Total Current Assets Annual Cr 292.548614.319916.107353.651409.374
Total Assets Annual Cr 791.5681138.4881442.0351673.4881781.751
INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Book Value Per Share Annual Rs 79.4305142.194266.748261.78972.8458
ROE Annual % -2.96-17.576.49-18.99-16.28
ROCE Annual % -0.9-6.01-33.81-2.964.78
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % 6.18-19.83-148.772.3923.23

Panacea Biotec Ltd Technicals

EMA & SMA

CURRENT PRICE

202.6 (0.57)

    • Bullish Moving Averages 1
    • Bearish Moving Averages 15

EMA

  • 20 Day

    208.41

  • 50 Day

    228.9

  • 100 Day

    253.65

  • 200 Day

    288.31

Panacea Biotec Ltd Resistance and support

204.89 PIVOT

  • First Resistance

    208.32

  • Second Resistance

    215.19

  • Third Resistance

    218.62

  • First Support

    198.02

  • Second Support

    194.59

  • Third Support

    187.72

  • RSI

    44.74

  • MFI

    43.8

  • MACD

    -3.95

  • MACD signal line

    -7.21

Panacea Biotec Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 103,952 5,293,236 50.92%
Week 217,329 13,281,000 61.11%
1 Month 206,936 11,091,785 53.6%
6 Month 226,554 11,067,153 48.85%

Panacea Biotec Ltd Price change analysis

-6.25

Over 1 month

Low High
163.8 237

-106.35

Over 3 month

Low High
163.8 311.55

-179.9

Over 6 months

Low High
163.8 412.3

-25.15

Over Year

Low High
163.8 453.7

Similar Stocks

News

PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under

This is with reference to CDSL's Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the s Read More

Panacea Biotec Ltd - 531349 - Clarification On Movement In P

We would like to state as under: 1. The Company has made all the necessary disclosures pursuant to Regulation 30 of the SEBI (Listing Obliga Read More

Panacea Biotec Ltd - 531349 - Clarification sought from Pana

The Exchange has sought clarification from Panacea Biotec Ltd on December 2, 2021 with reference to significant movement in price, in order Read More

Panacea Biotec Ltd - 531349 - Clarification On News Item App

We would like to state as under: 1. The Company's WOS, Panacea Biotec Pharma Limited ('PBPL') has issued Series 1A, Series 1B and Series 3 N Read More

Panacea Biotec Ltd - 531349 - Announcement under Regulation

In continuation to our letter dated November 12, 2021 for approving the Unaudited Standalone and Consolidated Financial Results (Provisional Read More

Blogs

FAQs

Stock Directory-

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All 0-9